SEC Info - Progyny, Inc. - ‘8-K’ for 11/28/22

SEC Info℠

Home

Help

Please Sign In

Progyny, Inc. – ‘8-K’ for 11/28/22

On: Monday, 11/28/22, at 8:15am ET · For: 11/28/22 · Accession #: 1551306-22-38 · File #: 1-39100

  As Of               Filer                 Filing    For·On·As Docs:Size

11/28/22  Progyny, Inc.                     8-K:7,9    11/28/22   11:213K

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     37K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     40K 
 6: R1          Cover                                               HTML     45K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 7: XML         XBRL Instance -- pgny-20221128_htm                   XML     22K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- pgny-20221128_lab                     XML     67K 
 5: EX-101.PRE  XBRL Presentations -- pgny-20221128_pre              XML     33K 
 3: EX-101.SCH  XBRL Schema -- pgny-20221128                         XSD     10K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    16K 
11: ZIP         XBRL Zipped Folder -- 0001551306-22-000038-xbrl      Zip     24K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

pgny-20221128

i 0001551306 i false00015513062022-11-282022-11-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): i November 28, 2022

i Progyny, Inc.

(Exact name of Registrant as Specified in Charter)



i Delaware	i 001-39100	i 27-2220139
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)



i 1359 Broadway i New York, i New York			i 10018
(Address of Principal Executive Offices)			(Zip Code)

i (212) i 888-3124

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:



i ☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

i Common Stock, $0.0001 par value per share

i PGNY

i The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On November 28, 2022, Progyny, Inc. (the “Company”) issued a press release to provide an update on the Company’s previously issued financial guidance for the three months and year ending December 31, 2022. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section. The information shall not be deemed incorporated by reference into any other filing with the Securities and Exchange Commission made by the Company, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit No.						Description
99.1						Press Release of Progyny, Inc. dated November 28 , 202 2
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



	Progyny, Inc.

Dated: November 28, 2022
	By:	/s/ *Peter Anevski*
		Peter Anevski
		Chief Executive Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

	12/31/22	None on these Dates
Filed on / For Period end:	11/28/22
		List all Filings

↑Top

Filing Submission 0001551306-22-000038 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)